ddTargets (Drug Targets / Disease Target Database): This is a unique and comprehensive database on therapeutic drug targets. This database contains drug targets reported in US patents or US/International patent applications and published research articles. The drug targets are also classified according to specific drug types (e.g. small molecule drugs, protein drugs, antibody drugs, siRNA drugs, miRNA drugs etc.) and disease types. The assays and methods used for characterizing each drug targets are listed as well. All the drug targets are linked to various databases such as PubMed (articles), Google Scholar (articles), GeneBank® (nucleotide sequence), UniProt (protein sequence), USPTO (full text patents/patent applications), WO(PCT) (full text international patent applications) and Google patents (full text US patents).

Bioprotocols

Comprehensive database of bioprotocols

New Products

Global Abundant Proteins Affinity Removal (GeneTel Laboratories)

Cancer-Leukemia - Combination Therapies

All


Apoptosis inducer and Magnetic nanoparticles
Aurora kinase inhibitors and Anti-CD20 antibody
BCR/ABL inhibitor and IFN-alpha
Ceramide-generating retinoid and 1-acylceramide synthase inhibitor
Ceramide-generating retinoid and 1-acylceramide synthase inhibitor and Sphingosine-1-phosphate synthesis inhibitors and Protein kinase C inhibitors
Ceramide-generating retinoid and Ceramide degradation inhibitor and Protein kinase C inhibitor and Sphingosine-1-phosphate synthesis inhibitor
Ceramide-generating retinoid and Ceramide degradation inhibitor and Sphingosine-1-phosphate synthesis inhibitor
CXCR4 inhibitor and VLA-4 inhibitor and CXCR2 agonist
Cyclic beta defensin derived peptide and Granulocyte colony-stimulating factor (G-CSF)
Dihydrofolate reductase inhibitor and Folic acid
DNA chain elongation inhibitor and Histone Deacetylase (HDAC) inhibitors and Topoisomerase inhibitor
DNA damaging agent and Chemotherapy and Radiation therapy
Id-1 inhibitor and Tetrahydrocannabinol
Inhibitor of the catalytic subunit of the protein phosphatase 1 (PP1) and Inhibitor of GADD34 and Inhibitor of the PP1/GADD34 complex and (Chemotherapy or Hormonotherapy or Immunotherapy or Specific kinase inhibitor-based therapy or Anti angiogenic agent based-therapy or Monoclonal antibody-based therapy)
PM02734 (kahalalide compounds) and EGFR tyrosine kinase inhibitor
Poly-ADP ribose polymerase 1 (PARP-1) inhibitor and Mrel l/Rad50/Nbsl (MRN) complex disruptor
pSTAT3 inhibitors and Cytotoxic agents or non-cytotoxic agents
Vanadium complexes and Antimicrotubule agent
Vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor and Tyrosine kinase enzyme inhibitor

Services offered

SciClips Consultancy

Fostering innovation through scientific intelligence

Sciclips consultancy service team is comprised of highly qualified and experienced scientists who have several years of research experience in academic and industrial laboratories. We offer following custom services at competitive price:

Scientific and technical areas covered: Drug discovery, Stem cells, Genomics, Proteomics, Biomarkers, Clinical diagnostics, Companion diagnostics, Molecular diagnostics, Personalized medicine (theranostics), Plant and agricultural biotechnology

Patent search

: Custom intellectual property (IP) analysis; Comprehensive patent database search and evaluation

Custom data analysis and data mining

: From patents, research articles, meeting abstracts and web based information. Custom meta analysis.

Competitive intelligence analysis

: Comprehensive analysis of competitive technologies and products; Technology trend prediction; Identification of technology licensing opportunities; Acquisition target identification; Identification of collaborative technology development opportunities.

Technology development

: Identification of potential development opportunities in drug discovery assay development, cell based assay development, recombinant protein expression (in vitro and in vivo) and mass spectrometry/proteomics reagents and tools; Product development strategy.

Diagnostics and Theranostics technology development

: Diagnostic assay development; Diagnostic target identification (molecular or protein or miRNA or metabolomic biomarkers); Prognostic and drug efficacy biomarkers; Theranostics tools, biomarkers and therapeutic drug targets; Identification of emerging technologies and methods.

Custom database development

Customized bioinformatics tools

: Offered through our partners.

Proteomics and Drug discovery services (laboratory based)

: Offered through our partners.

For more information on our consultancy services please contact us at contact@sciclips.com or email us using the contact form

Receive news updates by email

Search Drug Targets

Search Diseases

Keywords: High Content Screening, Cell Signaling Assays, Methyltransferase Assay, Drug Profiling Service, Pre-Clinical Services, Drug discovery assays, Cell based assays, HTS assays, clinical research services (CRO), GPCR cassays, receptor assays, kinase assays, phosphatase assays, toxicity assays, Reporter Assays,GPCR cell-based assays, Enzyme Inhibitors, screening molecules,Screening Assays,Screening compounds, Small Molecule Screening,Small Molecule Libraries, Raman Spectroscopy,kinase assays, protease assays, caspase assay,apoptosis assays, Receptor Assay, nuclear Receptor Assay,Receptor Binding Assay,Multiplex Assays, calcium assays, Ion Channel Screening, Sodium Channel Screening,HERG channel Assay,genotyping, ATP assay,Glutathione Assay, Genotoxicity assay,Flow Cytometry, Cell Proliferation Assay, Next generation sequencing, contract assay service, High Throughput Screening, Assay development, Drug Discovery Services, Cell based assays, Drug Profiling Service, Compound Profiling, Medicinal chemistry, ion channel assays